Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Landiolol Microcirculatory Effects in Postoperative Atrial Fibrillation
NCT03779178Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jan 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of landiolol in Atrial fibrillation (AFib), sponsored by Hospices Civils de Lyon. Started Jan 2019; status: completed.
02
Drugs
landiolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03779178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03779178.